Description:
MT-I is a synthetic analog of a-Melanocyte Stimulating Hormone (a-MSH) specifically developed for research into melanocortin receptor pathways. This linear heptapeptide demonstrates potent agonist activity at melanocortin receptors MCIR and MC3-5R, making it valuable for studying pigmentary responses, metabolic regulation, and neuroimmunomodulatory processes in
experimental models. In controlled research environments, MT-I has shown significant potential for stimulating melanogenesis through CAMP-mediated pathways in melanocyte cell cultures. The peptide appears to interact with key melanocortin receptors involved in pigment formation, appetite regulation, and inflammatory response modulation, providing researchers with a valuable tool for investigating melanocortin system function. This vial contains 10mg of lyophilized MT-I peptide, prepared under strict laboratory conditions for consistent research applications in dermatological, metabolic, and neurological studies.
Specifications:
unit Size: 10mg (lyophilized powder, single vial)
Form: White crystalline lyophilized powder
Molecular Weight: -1.1 kDa
Solubility: Soluble in sterile water or bacteriostatic water for research purposes
Sequence: Ac-Ser-Tyr-Ser-Nle-GIu-His-D-Phe-Arg-Trp-GIy-Lys- Pro-Val-NH2

Research Applications:
MT-I is utilized in vitro for investigation of.
Melanogenesis and pigmentary pathways in melanocyte cultures
Melanocortin receptor signaling and downstream effects
Metabolic regulation through central melanocortin pathways
Neuroimmunological interactions and inflammatory responses
29Comparative studies of melanocortin receptor subtype specificity